Pacer Advisors, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Pacer Advisors, Inc.
- $40.5 Billion
- Q4 2024
A detailed history of Pacer Advisors, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 2,279,918 shares of HRMY stock, worth $78.8 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
2,279,918
Previous 1,928,336
18.23%
Holding current value
$78.8 Million
Previous $77 Million
1.84%
% of portfolio
0.19%
Previous 0.18%
Shares
7 transactions
Others Institutions Holding HRMY
# of Institutions
255Shares Held
46.6MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$229 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$202 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$164 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$54.6 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.45MShares$50.1 Million2.2% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.04B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...